ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology
Series A round led by SBVA (SoftBank Ventures Asia) to help expand ImpriMed’s services beyond veterinary medicine into human oncology December 19, 2023 09:00 AM Eastern Standard Time MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–ImpriMed, a leading precision…